首页> 美国卫生研究院文献>Tissue Engineering. Part C Methods >Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion
【2h】

Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion

机译:聚二甲基硅氧烷微孔中造血干细胞/祖细胞和单层扩张间充质干细胞/造血细胞的球状共培养适度改善了体外造血干细胞/祖细胞的扩增。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

While two-dimensional (2D) monolayers of mesenchymal stem/stromal cells (MSCs) have been shown to enhance hematopoietic stem/progenitor cell (HSPC) expansion in vitro, expanded cells do not engraft long term in human recipients. This outcome is attributed to the failure of 2D culture to recapitulate the bone marrow (BM) niche signal milieu. Herein, we evaluated the capacity of a novel three-dimensional (3D) coculture system to support HSPC expansion in vitro. A high-throughput polydimethylsiloxane (PDMS) microwell platform was used to manufacture thousands of uniform 3D multicellular coculture spheroids. Relative gene expression in 3D spheroid versus 2D adherent BM-derived MSC cultures was characterized and compared with literature reports. We evaluated coculture spheroids, each containing 25–400 MSCs and 10 umbilical cord blood (CB)-derived CD34+ progenitor cells. At low exogenous cytokine concentrations, 2D and 3D MSC coculture modestly improved overall hematopoietic cell and CD34+ cell expansion outcomes. By contrast, a substantial increase in CD34+CD38 cell yield was observed in PDMS microwell cultures, regardless of the presence or absence of MSCs. This outcome indicated that CD34+CD38 cell culture yield could be increased using the microwell platform alone, even without MSC coculture support. We found that the increase in CD34+CD38 cell yield observed in PDMS microwell cultures did not translate to enhanced engraftment in NOD/SCID gamma (NSG) mice or a modification in the relative human hematopoietic lineages established in engrafted mice. In summary, there was no statistical difference in CD34+ cell yield from 2D or 3D cocultures, and MSC coculture support provided only modest benefit in either geometry. While the high-throughput 3D microwell platform may provide a useful model system for studying cells in coculture, further optimization will be required to generate HSPC yields suitable for use in clinical applications.
机译:尽管间充质干/基质细胞(MSC)的二维(2D)单层已显示出体外可增强造血干/祖细胞(HSPC)的扩增,但扩增的细胞无法长期植入人类受体。该结果归因于2D培养无法概括骨髓(BM)生态位信号环境。本文中,我们评估了新型三维(3D)共培养系统在体外支持HSPC扩展的能力。高通量的聚二甲基硅氧烷(PDMS)微孔平台用于制造数千个均匀的3D多细胞共培养球体。表征了相对基因表达在3D球体与2D贴壁BM来源的MSC培养物中的相对表达,并与文献报道进行了比较。我们评估了共培养的球体,每个球体包含25-400个MSC和10个脐带血(CB)衍生的CD34 + 祖细胞。在低外源性细胞因子浓度下,2D和3D MSC共培养适度改善了造血细胞的整体和CD34 + 细胞的扩增结果。相反,在PDMS微孔培养物中观察到CD34 + CD38 -细胞产量的显着增加,而与是否存在MSC无关。这一结果表明,即使没有MSC共培养支持,单独使用微孔平台也可以提高CD34 + CD38 -细胞的产量。我们发现,在PDMS微孔培养物中观察到的CD34 + CD38 -细胞产量的增加并未转化为NOD / SCIDγ(NSG)小鼠的植入增加,也没有转化为在移植小鼠中建立的相对人类造血谱系。总而言之,来自2D或3D共培养的CD34 + 细胞产量没有统计学差异,而MSC共培养支持在这两种几何结构中仅提供了适度的益处。尽管高通量3D微孔平台可为研究共培养细胞提供有用的模型系统,但仍需要进一步优化以产生适用于临床应用的HSPC产量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号